{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-002396","form_type":"8-K","ticker":"EXOZ","cik":"0002010788","company_name":"EXOZYMES INC.","filed_at":"2025-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.678114+00:00","generated_at":"2026-05-24T00:07:09.510900+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"eXoZymes provides Q4/FY2024 operational update; pre-revenue, advancing AI and commercialization","bullets":["Completed IPO on Nasdaq on Nov 13, 2024; trades as EXOZ.","Developed proprietary AI process to generate enzyme data, speeding up enzyme development.","Focus on commercialization via spin-outs, joint ventures, and licensing deals.","Remains pre-revenue; no financial results disclosed in the update.","CEO cites milestones toward first commercial applications as key focus."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-002396","json":"https://secwatch.observer/filing/0001641172-25-002396.json","markdown":"https://secwatch.observer/filing/0001641172-25-002396.md","text":"https://secwatch.observer/filing/0001641172-25-002396.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2010788/000164117225002396/0001641172-25-002396-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2010788/000164117225002396/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T00:07:09.510900+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}